These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 185806)

  • 41. Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.
    Chu MI; Fontaine P; Kutty KM; Murphy D; Redheendran R
    Clin Chim Acta; 1978 Apr; 85(1):55-9. PubMed ID: 206388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proceedings: Reciprocal fluctuations of lipoproteins in fasting therapy of hyperlipoproteinemia].
    Schellenberg B; Schlierf G; Oster P
    MMW Munch Med Wochenschr; 1975 May; 117(20):844. PubMed ID: 166301
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 44. [Musculoskeletal symptoms and hyperlipoproteinemia type IV].
    Nielsen PM; Pedersen SM
    Ugeskr Laeger; 1976 Jan; 138(4):223-5. PubMed ID: 175536
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum levels of thyroid-stimulating hormone in hyperlipoproteinemia.
    Vessby B; Wide L
    Clin Chim Acta; 1975 Jul; 62(2):293-7. PubMed ID: 168013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary hyperlipoproteinemia in xanthomatosis.
    Hessel LW; Vermeer BJ; Polano MK; De Jonge H; De Pagter HA; Van Gent CM
    Clin Chim Acta; 1976 Jun; 69(3):405-16. PubMed ID: 181183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood viscosity in ischemic heart disease with different types of hyperlipoproteinemia].
    Dudaev VA; Evdokimov VV
    Kardiologiia; 1977 Jun; 17(6):79-82. PubMed ID: 197288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of plasma viscosity in primary hyperlipoproteinaemia.
    Leonhardt H; Arntz HR; Klemens UH
    Atherosclerosis; 1977 Sep; 28(1):29-40. PubMed ID: 199202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of pyridoxine on patterns of lipid metabolism in patients with alimentary obesity].
    Frolova IA; Oleneva VA; Sirota II; Nikiforova GD
    Vopr Med Khim; 1975; 21(3):299-306. PubMed ID: 174303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diurnal changes in lipoproteins in patients with hyperlipoproteinemia type IV].
    Oster P; Seidel D; Schlierf G; Schellenberg B
    Verh Dtsch Ges Inn Med; 1975; 81():1442-3. PubMed ID: 179241
    [No Abstract]   [Full Text] [Related]  

  • 51. Two-dimensional immunoelectrophrophoretic pattern of low- and very-low-density lipoproteins, with particular reference to Fredrickson's type III.
    Rerabek JE
    Clin Chem; 1977 Feb; 23(2 PT. 1):186-94. PubMed ID: 188564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of gallbladder disease in hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Dig Dis Sci; 1979 Jun; 24(6):459-64. PubMed ID: 222561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility.
    Hazzard WR; Lindgren FT; Bierman EL
    Biochim Biophys Acta; 1970 May; 202(3):517-25. PubMed ID: 5442187
    [No Abstract]   [Full Text] [Related]  

  • 54. Study of 100 patients with bilateral sensorineural hearing loss for lipid abnormalities.
    Lowry LD; Isaacson SR
    Ann Otol Rhinol Laryngol; 1978; 87(3 Pt 1):404-8. PubMed ID: 207213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fasting serum bile acid levels in the primary hyperlipoproteinemias.
    Korman MG; Ellefson RD; Hofmann AF
    Mayo Clin Proc; 1975 Feb; 50(2):76-8. PubMed ID: 163941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity and hyperlipidaemia.
    Simons LA
    Med J Aust; 1976 Jun; 1(SP4):7-9. PubMed ID: 185502
    [No Abstract]   [Full Text] [Related]  

  • 57. Combined para-aminosalicylic acid and dietary therapy in long-term control of hypercholesterolemia and hypertriglyceridemia (Types IIa and IIb hyperlipoproteinemia).
    Kuo PT; Fan WC; Kostis JB; Hayase K
    Circulation; 1976 Feb; 53(2):338-41. PubMed ID: 173477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type IV and IIb hyperlipoproteinemia and the HLA system.
    Raffoux C; Pointel JP; Sauvanet JP; Drouin P; Janot C; Streiff F; Debry G
    Tissue Antigens; 1978 Sep; 12(3):212-4. PubMed ID: 83019
    [No Abstract]   [Full Text] [Related]  

  • 59. Pseudo-Sjögren syndrome with hyperlipoproteinemia.
    Goldman JA; Julian EH
    JAMA; 1977 Apr; 237(15):1582-4. PubMed ID: 576655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anxiety associated with hyperlipoproteinemia with and without obesity].
    Segers MJ; Mertens C; Vastesaeger M
    J Psychosom Res; 1975; 19(3):169-82. PubMed ID: 172628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.